SUBSCRIBE
SUBSCRIBE

Shuttle Pharmaceuticals

IN THE PRESS
Press Releases
Shuttle Pharma Provides Corporate Update
May 15, 2025
 · 
5 min read
Press Releases
Shuttle Pharma FDA Orphan-Drug Nears Patient Enrollment Milestone for Phase 2 Clinical Trial
May 9, 2025
 · 
4 min read
Press Releases
Shuttle Pharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025
April 22, 2025
 · 
3 min read
Press Releases
Shuttle Pharma Developing Pretreatment Diagnostic Blood Tests for Prostate Cancer, Files Provisional Patent for PSMA Ligand Conjugates to Treat Prostate Cancer
April 11, 2025
 · 
6 min read
Press Releases
Shuttle Pharma Announces Closing of $5.75 Million Underwritten Offering
March 14, 2025
 · 
4 min read
Press Releases
Shuttle Pharma Announces Pricing of $5.75 Million Underwritten Offering
March 13, 2025
 · 
4 min read
Press Releases
Shuttle Pharma Announces Appointment of Christopher Cooper as Interim Co-CEO to Enhance Business Activities
March 12, 2025
 · 
4 min read
Press Releases
Shuttle Pharma Provides Corporate Update and Reports 2024 Results
February 27, 2025
 · 
4 min read
Press Releases
Shuttle Pharma Reaches Milestone in Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma
January 21, 2025
 · 
5 min read
Press Releases
Shuttle Pharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025
January 8, 2025
 · 
4 min read
Load More
JOBS